
World-renowned Alzheimer’s researcher receives $300,000 UT System Faculty STARs award
November 20, 2024
Agustin Ruiz, MD, PhD, professor and director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases’ Biological Core laboratory and the Keith M. and Pat V. Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases at The Un …
UT Health San Antonio ranks among top 5% globally for clinical medicine
October 15, 2024
The race to draw the best and brightest students has become an international one, with candidates weighing options not only in their state or country, but also across the globe. Universities likewise face fierce competition globally for top scie …

UT Health San Antonio finds higher levels of leptin indicate brain protection against late-life dementia
September 18, 2024
Weight-maintaining hormone key to brain-signal transmission New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white m …

UT Health San Antonio finds genetic risk-factor overlap between Alzheimer’s disease, and all-cause and vascular dementias
September 17, 2024
In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic ri …

Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
July 31, 2024
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a poten …

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia
June 21, 2024
Study led partly by UT Health San Antonio suggests new prevention strategies Research led in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) finds that the most common cerebral small-vessel disease feature s …

UT Health Science Center San Antonio receives $1.5 million to advance cancer and Alzheimer’s research
May 10, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) recently received $1.5 million from the William and Ella Owens Medical Research Foundation to fund eight faculty members and their projects to advance research …

Studying a vaccine for Alzheimer’s disease in those with Down syndrome
March 18, 2024
Significant levels of amyloid beta plaques and tau tangles in the brain are classic hallmarks of Alzheimer’s disease. These precursors are also prevalent in the understudied population of those with Down syndrome.
UT System Rising STARs award to advance Alzheimer’s and neurodegenerative diseases research in South Texas
March 1, 2024
Margaret Flanagan, MD, associate professor/clinical in the Department of Pathology and Laboratory Medicine in the Joe R. and Teresa Lozano Long School of Medicine at the University of Texas Health Science Center at San Antonio (UT Health San Antonio) r …

University among top-ranking academic research medical centers
February 22, 2024
The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) received $131.5 million in National Institutes of Health funding in federal fiscal year 2023, according to the Blue Ridge Institute for Medical Rese …